62185-0042 NDC - BRAIN SUPPORT (ACETYLCHOLINE CHLORIDE, OCTOPAMINE, TAURINE, ADENOSINUM CYCLOPHOSPHORICUM, CEREBRUM (SUIS), DIENCEPHALON (SUIS), PINEAL GLAND (SUIS), THALAMUS OPTICUS (SUIS), ADRENALINUM, DOPAMINE HYDROCHLORIDE, GABA (GAMMA-AMINOBUTYRIC ACID), NOREPINEPHRINE (BITARTRATE), SEROTONIN (HYDROCHLORIDE))

Drug Information

Product NDC: 62185-0042

Proprietary Name: Brain Support

Non Proprietary Name: Acetylcholine Chloride, Octopamine, Taurine, Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Pineal Gland (Suis), Thalamus Opticus (Suis), Adrenalinum, Dopamine Hydrochloride, GABA (Gamma-Aminobutyric Acid), Norepinephrine (Bitartrate), Serotonin (Hydrochloride)

Active Ingredient(s):
  • 8 [hp_X]/mL .GAMMA.-AMINOBUTYRIC ACID;
  • 6 [hp_X]/mL ACETYLCHOLINE CHLORIDE;
  • 8 [hp_X]/mL ADENOSINE CYCLIC PHOSPHATE;
  • 8 [hp_X]/mL DOPAMINE HYDROCHLORIDE;
  • 8 [hp_X]/mL EPINEPHRINE;
  • 8 [hp_X]/mL NOREPINEPHRINE BITARTRATE;
  • 6 [hp_X]/mL OCTOPAMINE;
  • 8 [hp_X]/mL SEROTONIN HYDROCHLORIDE;
  • 8 [hp_X]/mL SUS SCROFA CEREBRUM;
  • 8 [hp_X]/mL SUS SCROFA DIENCEPHALON;
  • 8 [hp_X]/mL SUS SCROFA PINEAL GLAND;
  • 8 [hp_X]/mL SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS;
  • 6 [hp_X]/mL TAURINE


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Adrenergic alpha-Agonists [MoA];
  • Adrenergic beta-Agonists [MoA];
  • Catecholamine [EPC];
  • Catecholamine [EPC];
  • Catecholamine [EPC];
  • Catecholamines [CS];
  • Catecholamines [CS];
  • Catecholamines [CS];
  • Cholinergic Agonists [MoA];
  • Cholinergic Receptor Agonist [EPC];
  • alpha-Adrenergic Agonist [EPC];
  • beta-Adrenergic Agonist [EPC]

Labeler Information

Labeler Name: Dr. Donna Restivo DC
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:3/15/2019
End Marketing Date:4/15/2024

Package Information

No. Package Code Package Description Billing Unit
162185-0042-130 mL in 1 BOTTLE, DROPPER (62185-0042-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC62185-0042The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEBrain SupportThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAcetylcholine Chloride, Octopamine, Taurine, Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Pineal Gland (Suis), Thalamus Opticus (Suis), Adrenalinum, Dopamine Hydrochloride, GABA (Gamma-Aminobutyric Acid), Norepinephrine (Bitartrate), Serotonin (Hydrochloride)The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/15/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE4/15/2024This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDr. Donna Restivo DCName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; ADENOSINE CYCLIC PHOSPHATE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; NOREPINEPHRINE BITARTRATE; OCTOPAMINE; SEROTONIN HYDROCHLORIDE; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; TAURINEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH8; 6; 8; 8; 8; 8; 6; 8; 8; 8; 8; 8; 6 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023